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Limited data are available regarding the molecular epidemiology of Mycobacterium tuberculosis (Mtb)
strains circulating in Guatemala. Beijing-lineage Mtb strains have gained prevalence worldwide and are
associated with increased virulence and drug resistance, but there have been only a few cases reported in
Central America. Here we report the ﬁrst whole genome sequencing of Central American Beijing-lineage
strains of Mtb. We ﬁnd that multiple Beijing-lineage strains, derived from independent founding events,
are currently circulating in Guatemala, but overall still represent a relatively small proportion of disease
burden. Finally, we identify a speciﬁc Beijing-lineage outbreak centered on a poor neighborhood in
Guatemala City.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tuberculosis (TB) poses a major challenge to global health. The
causative agent,Mycobacterium tuberculosis (Mtb), was responsible
for around 1.5 million deaths in 2013 [1]. The seven major lineages
of Mtb have historically been associated with speciﬁc geographical
regions, and substantial evidence exists that genetic differences
between lineages inﬂuence disease presentation and outcome
[2e6]. Beijing lineage strains, also known as Lineage 2 strains, have
emerged as important drivers of globalMtb burden [7e9]. Notably,
outside of East Asia, “modern” Beijing strains account for theayoa), david.tobin@duke.edu
Ltd. This is an open access article umajority of this burden [10]. These “modern” Beijing strains display
elevated rates of drug-resistance, rapid progression of disease and
increased transmission [11e16]. While there is still debate as to
precisely when the Beijing lineage originated, it appears to have
arisen in East Asia and, through successive waves of human
migration, spread throughout this region and beyond [10,17]. Pos-
itive selection on virulence-associated genes as well as compen-
satory mutations negating the ﬁtness-cost of drug-resistance are
key factors in making Beijing the most successful contemporary
lineage [17e20].
The emergence of “modern” Beijing strains to new regions has
been particularly pronounced in Eastern Europe and Africa, regions
in which Euro-American strains are also present [21e23]. South
Africa serves as one striking example, where data suggest that
Beijing strains have continually expanded since their arrival to ac-
count for an increasing proportion of total burden [20]. Beijing
strains in South Africa have developed resistance to standard drug
therapies and contributed to poor outcomes for patients [24,25].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Neighbor-joining phylogeny based on 18,039 SNPs among 29 global strains
of Mtb. The tree is rooted by the outgroup M. canetti. Branches are colored by lineage:
Pink e Lineage 1/Indo-Oceanic; Blue e Lineage 2/East-Asian; Purple e Lineage 3/East-
African-Indian; Red e Lineage 4/Euro-American; Brown e Lineage 5/West-Africa I;
Green e Lineage 6/West Africa II; Yellow e Lineage 7/Ethiopia. Guatemalan isolates are
marked with stars. Scale bar indicates substitutions per site.
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has thus far been more complex. Beijing strains have spread across
the United States, with notable outbreaks occurring in New York
City, NY, and Houston, TX [26e28]. In contrast, South and Central
America have heretofore been thought to be relatively isolated
from this trend, and Euro-American/Lineage 4 strains predominate
[29e36]. Current evidence suggests Beijing strains have failed to
gain a foothold in South America outside of Peru, where a sub-
stantial number of Chinese and Japanese immigrants settled
throughout the 19th and 20th centuries [30]. However, there is very
little information on Mtb strain diversity in Central America. Thus
far, the sparse evidence that does exist indicates that Beijing strains
contribute only minimally to the burden of tuberculosis in the re-
gion [17,37].
Here we investigate the status of Beijing-lineage strains in
Guatemala, the most populous country in Central America. We take
a whole genome sequencing (WGS) approach to assess recent TB
cases at an HIV clinic and associated public hospital. We combine
our results with global genome sequences as well as epidemiologic
patient data to assess patterns of Beijing-lineageMtb in Guatemala.
2. Materials and methods
2.1. Patient population
The Clínica Familiar “Luis Angel García” (CFLAG) is an HIV-
specialized clinic located at the Hospital General San Juan de
Dios, one of Guatemala's two public teaching hospitals in
Guatemala City. It provides comprehensive treatment and follow-
up for people living with HIV for both outpatient and inpatient
care and has provided medical care for more than 10,000 patients
over the last thirty years. From 2010 to 2014, routine spoligotyping
was performed at CFLAG on all Mtb isolates from CFLAG and the
associated hospital during that period, derived from a total of 514
independent patients. Spoligotyping identiﬁed 11 Beijing-lineage
strains; ﬁve of the 11 strains could be regrown for WGS.
2.2. DNA extraction and genotyping
Bacterial culturing, spoligotyping, and DNA extraction were
performed according to standard practices (detailed in
Supplemental Material) [38,39].
2.3. Sequencing, alignment and SNP calling
Using Illumina HiSeq 2500 and Illumina MiSeq platforms, we
sequenced each strain at >500-fold coverage with a minimum read
length of 50 base pairs. Additional sequence reads acquired from
publishedWGS datasets also had minimum read lengths of 50 base
pairs. We downloaded reads from the National Center for
Biotechnology Information Sequence Read Archive and the Euro-
pean Nucleotide Archive, as described in [2,3,17,40]. We collected
sequence reads for 24 globally extant strains of Mtb representing
the seven major lineages [2,3,41], as well as 96 globally extant
Beijing strains [17]. We aligned reads against the H37Rv reference
genome (GenBank: AL123456.3) using BWA [42]. We called vari-
ants using SAMtools and ﬁltered with VarScan for a minimum read
depth of 10, a consensus quality score of 20, and aminimumvariant
frequency of 0.75 [43,44]. We discarded SNPs adjacent to indels and
within repetitive regions of the genome. Additionally, as is standard
practice, we discarded SNPs affecting genes commonly associated
with drug-resistance to avoid homoplastic mutations among
distantly related strains [10,17,45]. We visualized variants among
the Guatemalan isolates associated with the outbreak with Circular
Visualization for Microbial Genomes (URL: http://civi.cmbi.ru.nl/).2.4. Nucleotide sequence accession numbers
The sequences determined in this study have been deposited in
the NCBI Sequence Read Archive under accession numbers: GG-
135-10 e SRR1765871, GG-120-10 e SRR1765872, GG-152-12 e
SRR1765877, GG-131-11 e SRR1765874, GG-219-11 e SRR1765879,
and GG-30-13 e SRR1765888. GG-219-11 and GG-30-13 were
sequential isolates taken from the same patient 17 months apart.2.5. Tree builds
All trees were based on genome-wide SNPs derived according to
the parameters speciﬁed above. We constructed a superset of SNPs
for each strain with reference alleles occupying sites for which no
variants were detected using custom Perl scripts. These SNPs
informed neighbor-joining and maximum-likelihood methods of
phylogeny construction. We implemented neighbor-joining meth-
odology with ClustalW2 using pairwise similarity scores of SNP
supersets as a measure of genetic distance [46]. We generated a
maximum-likelihood phylogeny with RAxML using a GTR model of
nucleotide substitution [47]. For each method, 1000 bootstrap
replicates provided support for nodes on the tree. The phylogenies
derived from each method were congruent (compare Figure 2 to
Figure S1). Trees were visualized with FigTree (see URL tree.bio.ed.
ac.uk/software/ﬁgtree).
Figure 2. Neighbor-joining phylogeny based on 6584 SNPs among 101 global Beijing isolates of Mtb. Guatemalan isolates are indicated in orange. Scale bar indicates substitutions
per site.
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3.1. Spoligotyping of Mtb strains in Guatemala city
Euro-American strains of Mtb have historically been thought to
prevail in Central America, with very little contribution from Bei-
jing strains. In a collection of 514 patient isolates collected from
2010 to 2014 in by the Hospital San Juan de Dios and CFLAG, we
identiﬁed 11 (2.1%) with Beijing-lineage spoligotypes. Isolates
during this time period came from both HIV-positive and HIV-
negative patients. Patients with Beijing-lineage strains included
individuals living in the capital, Guatemala City, as well as two
patients from rural departments (Table 1).
Because no Beijing-lineage cases had been sequenced from
Guatemala, we sought to further investigate the identity of these
strains by WGS. Beyond identifying strain background, the resolu-
tion of WGS allows analysis of microevolution among closely
related isolates, and offers insight into the transmission history of
related strains [48]. We attempted to culture isolates retrospec-
tively from all 11 patients, but only ﬁve of these isolates could be
regrown in sufﬁcient quantities for WGS (Table 1).
3.2. Phylogeny of Guatemalan Beijing-lineage strains
We used a sample of 24 globally extant strains of Mtb, repre-
sentative of the seven major lineages, to initially place theGuatemalan Beijing strains in a broad phylogenetic context [3,40].
Neighbor-joining and maximum-likelihood methods of phylogeny
construction based on 18,039 genome-wide SNPs resolved all 29
strains into the seven principal lineages of Mtb, and placed the
Guatemalan isolates among known Beijing strains (see Methods)
(Figure 1). To independently conﬁrm the identity of these strains as
Beijing-lineage, we searched for previously identiﬁed Beijing-
speciﬁc variants. All ﬁve Guatemalan isolates harbored the Beijing
lineage ACG- > AGG SNP in codon 20 of Rv2450c and the GGG-
> AGG SNP in codon 176 of Rv2952 (Supplemental Table 1), con-
ﬁrming their status as Beijing strains [41].
To understand the relationship of the Guatemalan Beijing
strains to other globally extant Beijing strains, we generated
phylogenetic trees based on 6584 SNPs among a total of 101
Beijing strains (see Methods) [17]. The Guatemalan strains were
distributed on three independent branches in all constructed
trees (Figure 2 and Figure S1). Three isolates (GG-131-11, GG-219-
11, and GG-152-12) clustered on a single branch of the tree near
strains previously identiﬁed in China and Thailand. A fourth
isolate, GG-120-10, fell on an independent branch of the phylo-
genetic tree, and is most closely related to strains identiﬁed in
Nepal. Finally, one of the Guatemalan patient isolates, GG-135-10,
appeared to represent a more basal sublineage, and clustered
with the so-called “ancient” Beijing strains. Notably, none of the
isolates came from individuals who reported travel outside of
Guatemala.
Table 1
Spoligotypes and patient risk factors for the 11 identiﬁed Beijing isolates from the Clínica Familiar “Luis Angel García” (CFLAG) and its associated public hospital.
Isolate Spoligotype Predicted
lineage
WGS
performed
Lineage
by WGS
Risk factors Residence Year
of Isolation
GG-120-10 000000000003770 Beijing Yes Beijing HIV positive Urban 2010
GG-135-10 000000000003770 Beijing Yes Beijing HIV positive Rural Department 2010
GG-22-10 000000000003771 Beijing No e HIV negative Urban 2010
GG-206-10 000000000003771 Beijing No e HIV negative Urban, near local jail 2010
GG-32-10 000000000003771 Beijing No e HIV status unknown Urban, near local jail 2010
GG-131-11 000000000003771 Beijing Yes Beijing HIV positive Urban, near local jail 2011
GG-219-11 000000000003770 Beijing Yes Beijing HIV positive; history of incarceration History of incarceration in local jail 2011
GG-152-12 000000000003770 Beijing Yes Beijing HIV positive; history of incarceration History of incarceration in local jail 2012
GG-10-14 000000000003771 Beijing No e HIV positive; history of incarceration Urban; history of incarceration in local jail 2014
GG-107-14 000000000003771 Beijing No e HIV negative Rural Department 2014
GG-109-14 000000000003771 Beijing No e HIV negative Urban 2014
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distance was consistent with multiple introductions of Beijing
strains into the country. Approximately 500 SNPs separated GG-
135-10 from the four other Guatemalan isolates, and GG-120-10
differed from GG-131-11, GG-219-11, and GG-152-12 by ~200
SNPs (Supplemental Table 1). The last three isolates were highly
similar, differing by at most 31 SNPs, suggestive of a recently shared
progenitor strain (detailed further below).
Phylogenetic analysis indicated GG-120-10, GG-131-11, GG-219-
11 and GG-152-12 are evolutionary “modern” Beijing strains, while
GG-135-10 is of an ancestral Beijing sublineage. Thus, we assessed
each Guatemalan isolate for the insertion variant T1406760 þ G in
Rv1258c, as this variant is known to be a marker for the “modern”
Beijing genotype [49]. As expected, four isolates displayed this
polymorphism: GG-120-10, GG-131-11, GG-219-11, and GG-152-12.
As additional conﬁrmation, the four “modern” Beijing strains also
harbored a GGA- > CGA mutation at codon position 58 in the DNA
repair enzyme genemutT2, yet GG-135-10 did not [8,50]. Together,
these data reveal that both evolutionarily “modern” and “ancient”
Beijing strains are present in Guatemala.3.3. Epidemiologic analysis of a Beijing-lineage outbreak in
Guatemala city
We noted that three Guatemalan Beijing-lineage isolates (GG-
131-11, GG-219-11, and GG-152-12) demonstrated a tight clustering
on one branch of the tree, indicating transmission of a single
founder strain (Figure 2). 125 SNPs separate this clade from its
nearest neighbor on the tree (8662-05) (Figure 3). Of these, 94 SNPs
are shared among all three strains. 18 SNPs are unique to GG-131-
11, and 13 unique to GG-219-11 and GG-152-12. The patients
from whom GG-219-11 and GG-152-12 were isolated had spent
time within the same city jail, but their incarceration periods had
not overlapped. Isolates from these two patients were the most
closely related strains we identiﬁed, varying from each other by
only 1 SNP. One variant shared between these two strains includes
a GAC- > AAC mutation in codon 94 of the DNA gyrase gene gyrA, a
mutation reported to associate with ﬂuoroquinolone-resistance
[51,52].
The closely related strain GG-131-11 differed from the jail iso-
lates by 31 SNPs, and did not contain the gyrA variant. This patient
lived in the same neighborhood as the jail where the patients had
resided, but the third patient had no other known connection other
than residence in the vicinity of the jail. Among the six strains
identiﬁed as Beijing, but for which WGS could not be performed,
two of them derived from HIV-negative patients who also lived in
the same neighborhood as the jail (Table 1). In total, six of the 11
identiﬁed Beijing-lineage cases were centered on this same
neighborhood.Finally, the HIV-positive patient (Table 1) fromwhom strain GG-
219-11 was isolated abandoned treatment completely and then
returned to the clinic 17 months later, at which time a second
isolate (GG-30-13) was obtained. A comparison of the sequential
isolates revealed a single variant between the initial isolate and that
taken after 17 months of untreated disease. These data reﬂect a
relatively low mutation rate for this particular Beijing-lineage
strain in the absence of antibiotic therapies and in the context of
a compromised immune system.4. Discussion
In this study, we use WGS to investigate Beijing Mtb strains
circulating in Guatemala. The Beijing lineage, which has emerged
globally, is considered generally more virulent than strains of
other lineages, and has a higher frequency of drug-resistance
[11e16]. Prior to this study, information on Beijing isolates in
Guatemala has been sparse [5]. Here, we have for the ﬁrst time
conducted WGS on Beijing isolates from Central America for an in-
depth characterization of the potential regional emergence of
these strains.
We infer from WGS and phylogenetic analysis that multiple
Beijing strains have been introduced into Guatemala and that these
strains have transmitted within Guatemala itself; notably, none of
the affected patients has any history of travel outside Guatemala,
strongly suggesting in-country circulation of each strain. Patients
infected with Beijing-lineage strains included both HIV-negative
and HIV-positive individuals. Central and South America have
traditionally been thought to harbor almost exclusively Euro-
American Mtb strains [29e36]. Here we conﬁrm the presence of
circulating Beijing strains in Central America and link one set of
strains to an outbreak in an urban setting.
We were able to connect patients through a combination of
strain sequences and epidemiology. We identiﬁed an outbreak of
one Beijing-lineage strain in a poor neighborhood in urban
Guatemala centered on a city jail. Two of the cases were patients
who had resided in the jail but not during overlapping time periods,
suggesting the presence of other latently or undiagnosed actively
infected inmates. Indeed, one of the unsequenced but spoligotype-
identiﬁed Beijing strains (Table 1, strain GG-10-14) was from a
patient who had spent time in the same jail in 2008. The Beijing-
lineage outbreak strain does not represent the only Mtb strain
within the jail. Therewere eight additional TB cases associatedwith
the jail that, by spoligotyping, were identiﬁed as Euro-American/
Lineage 4 strains (T1, X1, H2, LAM3, LAM9 families) (D.L.-B., N.M.,
E.A. and B.S., unpublished results).
Of the 11 Beijing isolates we identiﬁed, six were associated with
a local jail or the neighborhood directly around it. Although we
were unable to identify direct epidemiologic links between the
Figure 3. Circular diagram of polymorphisms unique to the Guatemalan micro-outbreak strains plotted on the H37Rv reference genome. The outer wheel displays base pair
coordinates. The second and third wheels represent positive- and negative-strand genes, respectively. Circles four through seven display genome positions of the 125 poly-
morphisms that separate the Guatemalan outbreak isolates from their nearest neighbor (8662-05) on the tree. The purple shaded wheel with yellow dots displays the 94 SNPs
shared among all three isolates. The blue shaded wheel with orange dots displays the 18 SNPs speciﬁcally found in GG-131-11 (star denotes presence of two SNPs that are too close
to resolve on the diagram). The red wheels display SNPs found in the jail-associated isolates GG-219-11 (outer, blue dots) and GG-152-12 (inner, green dots). The innermost circle
represents GC-skew.
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phylogenetic clustering is striking. Workers in the jail (guards and
other staff), exiting inmates, and proximity to public bus lines
within the neighborhood are possible links between the commu-
nity and the jail. Consistent with previous results on outbreak
strains of Mtb and rates of divergence, the clustering of these cases
as well as substantial nucleotide divergence (31 SNPs) between the
neighborhood and jail-associated strains suggests an outbreak that
has lasted a number of years and the presence of other unidentiﬁed
patients in the area [53e56]. The mutation rate ofMtb is estimated
to be between 0.3 and 0.5 SNPs per year, and it has been proposed
that a maximum of ﬁve SNPs separating isolates indicate ongoing
transmission [54e56]. However, one study demonstrated an
epidemiological link between strains that differed by 14 SNPs, and
bursts of mutations have been shown to occur in clinical isolates of
Mtb [57,58]. Together, these results suggest the founder strain
arrived in Guatemala City and infected a citizen who entered the
jail (either an employee or inmate), thereby establishing clonal
transmission of this isolate within the jail's population. The strain's
entry into the jail likely initiated its divergence from related isolates
circulating in the broader community.In spite of no known anti-tuberculosis therapy for these patients
prior to diagnosis, we identiﬁed a mutation that arose in the iso-
lates and was associated with resistance to ﬂuoroquinolones [51].
This mutation may have arisen in a progenitor strain due to the use
of over-the-counter antibiotics, readily available in Guatemala, or
through prescription from another practitioner. Regardless, this
ﬁnding highlights the issue of emergent ﬂuoroquinolone-resistant
Beijing-lineage strains in countries with easy over-the-counter
access to antibiotics.
Overall, we describe multiple circulating Beijing strains that
have been introduced independently into Guatemala, including an
“ancient” Beijing strain. However, the overall contribution to dis-
ease burden in Guatemala City still appears relatively low, with 11
Beijing isolates out of 514 reported cases (2.1%), in line with reports
from other Central and South American countries [29e37]. Gua-
temalan immigrants to the United States with active TB show
similar rates of infection with Beijing strains (2% of 609 genotyped
cases reported 2009e2013, as compared with 15% prevalence of
Beijing strains among all TB cases reported in the US in the same
period) (Smita Ghosh, Centers for Disease Control and Prevention,
personal communication).
J.W. Saelens et al. / Tuberculosis 95 (2015) 810e816 815The emergence of the Beijing lineage in Guatemala has impor-
tant implications for public health in Central America, where no
WGS on Mtb had been performed previously. More broadly, this
work helps increase our understanding of the global spread of the
Beijing lineage, which presents particular challenges in combating
TB.
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